Mak Gerald, Nesbitt Craig, Shiraev Tim, Wang Cindy, Doane Matthew, Neale Michael
Department of Vascular Surgery, Royal North Shore Hospital, Sydney, Australia.
Department of Anaesthesia, Royal North Shore Hospital, Sydney, Australia.
J Vasc Surg Cases Innov Tech. 2020 Sep 23;6(4):614-617. doi: 10.1016/j.jvscit.2020.09.008. eCollection 2020 Dec.
Arteriovenous fistula (AVF) is an uncommon presentation of ruptured aortoiliac aneurysm (rAIA). Symptomatic persistence of an AVF fed by a type II endoleak after endovascular aneurysm repair (EVAR) for rAIA is rare, with little in the literature to guide practice. We present a novel transvenous approach to treatment of symptomatic type II endoleak after EVAR for rAIA with AVF. A transvenous approach avoids complex arterial access and the need for stenting in the venous system. This technique should be considered in patients with persistent AVF after EVAR with ongoing symptomatic type II endoleak.
动静脉瘘（AVF）是破裂性主髂动脉瘤（rAIA）的一种罕见表现。在对rAIA进行血管内动脉瘤修复（EVAR）后，由II型内漏供血的AVF出现症状性持续存在的情况较为罕见，文献中几乎没有可指导实践的内容。我们提出了一种新颖的经静脉方法，用于治疗EVAR术后rAIA合并AVF的症状性II型内漏。经静脉方法避免了复杂的动脉入路以及静脉系统中支架置入的需求。对于EVAR术后出现持续性AVF且伴有症状性II型内漏持续存在的患者，应考虑采用这种技术。
